These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36979969)

  • 1. Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis.
    Carli ALE; Hardy JM; Hoblos H; Ernst M; Lucet IS; Buchert M
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.
    Patel O; Dai W; Mentzel M; Griffin MD; Serindoux J; Gay Y; Fischer S; Sterle S; Kropp A; Burns CJ; Ernst M; Buchert M; Lucet IS
    Structure; 2016 Sep; 24(9):1550-61. PubMed ID: 27545623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural studies of the doublecortin family of MAPs.
    Fourniol F; Perderiset M; Houdusse A; Moores C
    Methods Cell Biol; 2013; 115():27-48. PubMed ID: 23973064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doublecortin-like kinase 1 compromises DNA repair and induces chromosomal instability.
    Lu Y; Maruyama J; Kuwata K; Fukuda H; Iwasa H; Arimoto-Matsuzaki K; Sugimura H; Hata Y
    Biochem Biophys Rep; 2018 Dec; 16():130-137. PubMed ID: 30417131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCLK1 autoinhibition and activation in tumorigenesis.
    Cheng L; Yang Z; Guo W; Wu C; Liang S; Tong A; Cao Z; Thorne RF; Yang SY; Yu Y; Chen Q
    Innovation (Camb); 2022 Jan; 3(1):100191. PubMed ID: 34977835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoregulatory control of microtubule binding in doublecortin-like kinase 1.
    Agulto RL; Rogers MM; Tan TC; Ramkumar A; Downing AM; Bodin H; Castro J; Nowakowski DW; Ori-McKenney KM
    Elife; 2021 Jul; 10():. PubMed ID: 34310279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for specific regulation of neuronal kinesin-3 motors by doublecortin family proteins.
    Liu JS; Schubert CR; Fu X; Fourniol FJ; Jaiswal JK; Houdusse A; Stultz CM; Moores CA; Walsh CA
    Mol Cell; 2012 Sep; 47(5):707-21. PubMed ID: 22857951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1.
    Patel O; Roy MJ; Kropp A; Hardy JM; Dai W; Lucet IS
    Commun Biol; 2021 Sep; 4(1):1105. PubMed ID: 34545159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis of Inhibition of DCLK1 by Ruxolitinib.
    Jang DM; Lim HJ; Hahn H; Lee Y; Kim HK; Kim HS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanism of Mutational Disruption of DCLK1 Autoinhibition Provides a Rationale for Inhibitor Screening.
    Chen W; Liu R; Yu Y; Wei D; Chen Q; Xu Q
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional implication of Dclk1 and Dclk1-expressing cells in cancer.
    Westphalen CB; Quante M; Wang TC
    Small GTPases; 2017 Jul; 8(3):164-171. PubMed ID: 27458755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative transcripts of Dclk1 and Dclk2 and their expression in doublecortin knockout mice.
    Tuy FP; Saillour Y; Kappeler C; Chelly J; Francis F
    Dev Neurosci; 2008; 30(1-3):171-86. PubMed ID: 18075264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Progress of DCLK1 Inhibitors as Cancer Therapeutics.
    Cheng L; Huang S; Chen L; Dong X; Zhang L; Wu C; Ye K; Shao F; Zhu Z; Thorne RF
    Curr Med Chem; 2022; 29(13):2261-2273. PubMed ID: 34254905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural transitions in the GTP cap visualized by cryo-electron microscopy of catalytically inactive microtubules.
    LaFrance BJ; Roostalu J; Henkin G; Greber BJ; Zhang R; Normanno D; McCollum CO; Surrey T; Nogales E
    Proc Natl Acad Sci U S A; 2022 Jan; 119(2):. PubMed ID: 34996871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells.
    Carli ALE; Afshar-Sterle S; Rai A; Fang H; O'Keefe R; Tse J; Ferguson FM; Gray NS; Ernst M; Greening DW; Buchert M
    Proteomics; 2021 Jul; 21(13-14):e2000098. PubMed ID: 33991177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
    Wang J; Wang S; Zhou J; Qian Q
    Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
    Kang XL; He LR; Chen YL; Wang SB
    World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doublecortin facilitates the elongation of the somatic Golgi apparatus into proximal dendrites.
    Li P; Li L; Yu B; Wang X; Wang Q; Lin J; Zheng Y; Zhu J; He M; Xia Z; Tu M; Liu JS; Lin Z; Fu X
    Mol Biol Cell; 2021 Mar; 32(5):422-434. PubMed ID: 33405953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.
    Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW
    Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.